Patent ID: 11897898
Assignee: BIOGEN MA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The compound of claim 1, wherein:
R1 in each occurrence is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, 4- to 7-membered monocyclic non-aromatic heterocyclyl, 5- to 6-membered N-containing heteroaryl, 6- to 8-membered spiro or bridged bicyclic heterocyclyl, halo, —CN, —C(O)R1a, —C(O)OR1a, —C(O)N(R1a)2, —N(R1a)2, —OR1a, —S(O)2R1a, and —S(O)2N(R1a)2, wherein said C1-6alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, 4- to 7-membered monocyclic non-aromatic heterocyclyl, 5- to 6-membered N-containing heteroaryl, and 6- to 8-membered spiro or bridged bicyclic heterocyclyl are optionally substituted with one to four R10;
R1a in each occurrence is independently selected from H, C1-6 alkyl, and 4- to 7-membered monocyclic N-containing non-aromatic heterocyclyl, wherein said C1-6 alkyl, and 4- to 7-membered monocyclic N-containing non-aromatic heterocycly are optionally and independently substituted with one to three R10; and
R10 in each occurrence is independently selected from C1-6 alkyl, halo, —N(R10a)2, —OR10a, —C(O)OR1a, —CN, C3-6 cycloalkyl, and 4- to 7-membered monocyclic non-aromatic heterocyclyl, wherein said C1-6 alkyl, C3-6 cyloalkyl, and 4- to 7-membered monocyclic non-aromatic heterocyclyl are optionally substituted with one to three substituents independently selected from halo, —CN, —C(O)R10a, —C(O)OR10a, —C(O)N(R10a)2, —N(R10a)2, —N(R10a)C(O)R10a, —N(R10a)C(O)OR10a, —N(R10a)C(O)N(R10a)2, —N(R10a)S(O)2RR10a, —OR10a, —OC(O)R10a, —OC(O)N(R10a)2, —SR10a, —S(O)R10a, —S(O)2R10a, —S(O)N(R10a)2, and —S(O)2N(R10a)2; and
R10a in each occurrence is independently H or C1-4 alkyl.